Bio-Rad Laboratories Profit Margin

Bio-Rad Laboratories's profit margin stands at 39.45% as of September 2026. That compares with -28.93% in the prior-year period — up 236.4% year over year. That is above the Healthcare sector average of 17.63%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Bio-Rad Laboratories reported 39.45% in profit margin versus -28.93% a year earlier — a 236.4% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Bio-Rad Laboratories sits higher the Healthcare benchmark (17.63%) with a profit margin of 39.45%. That is roughly 123.8% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 39.45% for Bio-Rad Laboratories means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Bio-Rad Laboratories's profit margin evolved across reporting periods, while the comparison chart places BIO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.